Skip to main content
. Author manuscript; available in PMC: 2014 Jan 28.
Published in final edited form as: J Clin Oncol. 2008 Mar 24;26(13):2171–2177. doi: 10.1200/JCO.2007.14.1853

Table 2.

Response to Therapy

%
Criteria Thalidomide
Plus
Dexamethasone
(n = 235)
Dexamethasone
(n = 235)
P
Overall response (CR + PR) 63 46 < .001
CR 7.7 2.6
PR 55.3 43.4
CR + VGPR (IMWG criteria) 43.8 15.8 < .001

Abbreviations: CR, complete response; PR, partial response; VGPR, very good PR; IMWG, International Myeloma Working Group.